Preliminary Claims Analysis from Leading Price Transparency Firm Identifies Massive COVID-19 Testing Price Variations

Independent research finds COVID-19 testing costs can vary by hundreds of dollars per test, with billions of dollars at risk nationwide

Portsmouth, NH—May 6, 2020—MMS Analytics Inc., dba MyMedicalShopper, a leading provider of healthcare price transparency solutions and big data analytics, has identified significant variations in COVID-19 testing costs to patients, with billions of dollars in potential waste at stake across mass population testing efforts.

“Our analysis exemplifies the need for price transparency across the entire healthcare system,” said CEO of MMS Analytics, Inc., Mark Galvin. “The industry has taken steps to limit the financial burden of COVID-19 testing and treatment on consumers, which is obviously a benefit to all patients who need care during this health crisis. Still, the impact of coronavirus-related testing and treatment on future health insurance premiums is only now beginning to take shape. It is the total cost of this care—not just the patient responsibility portion of it—that will drive the cost of our health insurance down the road.”

After analyzing tests from both official CDC and non-official CDC testing facilities, MMS Analytics Inc., dba MyMedicalShopper found that:

  • Charged amounts range from $51 to $351
  • Allowed amounts (the insurance-negotiated discounted amounts actually paid) range from $39 to $157

“While it’s still early in the collection and analysis process, our early findings on COVID-19 DNA/RNA identification tests expose yet another example of significant variation in medical care prices,” said Evan Young, Head of Data Analytics for MMS Analytics, Inc. “Based on our preliminary analyses, it appears that the price differences for these COVID-19 tests are similar to the differences we observe across thousands of other types of routine medical care. Providing patients with accurate and timely information about cost and quality, as has always been the case, remains an essential step towards mitigating our collective exposure to unnecessary insurance costs over the long term.”

The full report is available here.

About MMS Analytics, Inc. ( 

MMS Analytics, Inc. dba MyMedicalShopper™ is a big data company on a mission to build technology, products, and services to drive meaningful savings from the cost of healthcare in the United States. The company was founded on the belief that fixing the broken healthcare marketplace required a focus on the alignment of financial incentives, medical price transparency, and the reduction of administrative overhead. The company empowers employers and their employees with the ability to choose care based on price, quality, and convenience with unprecedented access to the previously secretive prices negotiated between insurance carriers and providers. Experts document that as much as $1 trillion could be slashed annually from the cost of healthcare in the United States. MyMedicalShopper aims to help transform the healthcare industry into a fair market for consumers.



Christopher Matrumalo

(603) 292-3020


Download the full Planning Guide
Ensuring Compliance with the No Surprises Act and Transparency in Coverage Rule